Brian Goodman

Brian Goodman currently serves as Managing Director at Vida Ventures, LLC, starting in April 2025. Previously, Brian held notable positions including Member of the Board of Directors at Antiva Biosciences, Inc. and Partner at MPM BioImpact. Brian was a cofounder and held various executive roles at Aktis Oncology and ReNAgade Therapeutics. Additionally, Brian was a member of the Board of Directors at Orna Therapeutics and played a key role at Evelo Biosciences, focusing on innovative cancer therapies. Early career experiences include positions at Flagship Ventures and a PhD candidacy at Harvard Medical School, where Brian studied biochemistry. Education includes a BS/BA in Biochemistry and Economics from Brandeis University.